AIDS Alert Archives – August 1, 2008
August 1, 2008
View Issues
-
CA's streamlined HIV testing uncovering hidden infections
A new study highlighting California's experiences with HIV testing since the state removed legal barriers demonstrates that routine testing in medical settings will prove to be a good testing, prevention, and care strategy for states to adopt. -
Adherence Strategies: Fine-dining gives patients incentive to stay on meds
At least this is what one HIV clinic discovered after starting an HIV medication adherence program that rewards patients who achieve 95 percent adherence to medication regimens and clinic appointments with a dinner out at an upscale restaurant. -
New CCR5 antagonist enters phase II trials
A new CCR5 receptor antagonist called vicriviroc may become a key weapon in the antiretroviral arsenal. -
FDA Notifications: Generic zidovudine oral solution approved
On June 26, 2008, the Food and Drug Administration (FDA) granted approval for a generic Zidovudine Oral Solution USP, 50 mg/5 mL formulation manufactured by Cipla Limited of Mumbai, India. -
NYC reports spate of HIV false positives with oral test
Episodic, unexplained false positive results with an oral fluid rapid HIV test, have resulted in changed protocols in some clinics and an ongoing investigation by the Centers for Disease Control and Prevention. -
Roche Labs update insert for saquinavir
Roche Laboratories, Inc. has updated their package insert for their protease inhibitor, saquinavir (Invirase) to include the following drug interaction information and include new warnings regarding coadministration of saquinavir/ritonavir and digoxin (used in the treatment of various cardiac conditions). -
With long hours, less staff nurses fear needlesticks
Needlesticks a problem some may have thought solved by needle safety devices remain a top concern among nurses. -
While other groups decline, HIV increasing in MSM
During 2001-2006, male-to-male sex remained the largest HIV transmission category in the United States and the only one associated with an increasing number of HIV/AIDS diagnoses, according to new data by the Center for Disease Control and Prevention reports.